Safe Orthopaedics05.19.16
Safe Orthopaedics, a company offering ranges of sterile implants combined with their single-use instruments, has performed the first surgeries with its new SteriSpineCC range for cervical vertebrae procedures.
Designed, like all Safe Orthopaedics’ products, for single use, the SteriSpineCC kit offers the same benefits—ease of use with its sterile instrumentation pre-mounted on the implant that shortens operating times and reduces the cost of the procedure, while improving patient safety and ensuring availability at all times. Extending the existing product range for lumbar and trauma surgery, this new addition applies Safe Orthopaedics’ technology in the field of single-use instruments for back surgery to cervical surgeries.
Protected by 17 patent families, the SteriSpine Kits are CE-marked and U.S. Food and Drug Aministration-cleared.
“The launch of SteriSpineCC represents another milestone in our expansion and in the execution of Safe Orthopaedics’ mission,” Interim CEO Pierre Dumouchel said. “We want to provide a solution facilitating the treatment of degenerative cervical conditions by delivering the combined benefits of a stable anatomical implant with our single-use instruments. This type of cervical surgery needs to be reliable, effective and rapid so that it can guarantee the best possible clinical outcome. This type of surgery opens the door to fast-track and outpatient surgery.”
To date, four surgeries have been carried out by Prof. Jean-Charles Le Huec, head of the orthopedics-spine trauma unit at Bordeaux University Hospital (France), and by Dr. Antonio Faundez, a surgeon at Hôpital de la Tour in Switzerland.
“This new system is genuinely straightforward and makes the surgery safer by helping to reduce operating times,” noted Le Huec. “In this product I can see and appreciate the benefits of Safe Orthopaedics’ philosophy, which began with the SteriSpine PS and LC lumbar systems.”
“Always ready for use, the SteriSpineCC range is genuinely easy to use at every stage of the surgical process,” concluded Faundez.
The SteriSpineCC kit is scheduled for launch in the third quarter of 2016, entering a new market segment worth an estimated $500m1.
Founded in 2010, Safe Orthopaedics is an Eragny-sur-Oise, France-based developer and marketer of sterile implants and associated single-use surgical instruments designed to facilitate safer, optimized and lower-cost spinal surgery. The company has 37 employees.
Reference:
1. Millenium data.
Designed, like all Safe Orthopaedics’ products, for single use, the SteriSpineCC kit offers the same benefits—ease of use with its sterile instrumentation pre-mounted on the implant that shortens operating times and reduces the cost of the procedure, while improving patient safety and ensuring availability at all times. Extending the existing product range for lumbar and trauma surgery, this new addition applies Safe Orthopaedics’ technology in the field of single-use instruments for back surgery to cervical surgeries.
Protected by 17 patent families, the SteriSpine Kits are CE-marked and U.S. Food and Drug Aministration-cleared.
“The launch of SteriSpineCC represents another milestone in our expansion and in the execution of Safe Orthopaedics’ mission,” Interim CEO Pierre Dumouchel said. “We want to provide a solution facilitating the treatment of degenerative cervical conditions by delivering the combined benefits of a stable anatomical implant with our single-use instruments. This type of cervical surgery needs to be reliable, effective and rapid so that it can guarantee the best possible clinical outcome. This type of surgery opens the door to fast-track and outpatient surgery.”
To date, four surgeries have been carried out by Prof. Jean-Charles Le Huec, head of the orthopedics-spine trauma unit at Bordeaux University Hospital (France), and by Dr. Antonio Faundez, a surgeon at Hôpital de la Tour in Switzerland.
“This new system is genuinely straightforward and makes the surgery safer by helping to reduce operating times,” noted Le Huec. “In this product I can see and appreciate the benefits of Safe Orthopaedics’ philosophy, which began with the SteriSpine PS and LC lumbar systems.”
“Always ready for use, the SteriSpineCC range is genuinely easy to use at every stage of the surgical process,” concluded Faundez.
The SteriSpineCC kit is scheduled for launch in the third quarter of 2016, entering a new market segment worth an estimated $500m1.
Founded in 2010, Safe Orthopaedics is an Eragny-sur-Oise, France-based developer and marketer of sterile implants and associated single-use surgical instruments designed to facilitate safer, optimized and lower-cost spinal surgery. The company has 37 employees.
Reference:
1. Millenium data.